MedWatch

A part of Watch Media

Analyst: Listed subsidiary may pave the way for WSA and take chunk out of massive debt

WS Audiology's subsidiary Hear.com going public could shave down a sizeable chunk of the hearing aid firm's billion kroner debt, according to a CIB analyst. He notes that when the subsidiary goes public this will generate positive attention around WSA which can positively impact the possibility of WSA getting listed.

Photo: WS Audiology / PR
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN

On Tuesday, Danish hearing aid company WS Audiology garnered attention due to its announcement that it would be taking its Dutch-domiciled subsidiary Hear.com public on the US stock exchange.

Carnegie Investment Bank Head of Equity Research and long-time hearing industry analyst Niels Granholm-Leth holds that this decision is rooted in some rational explanations.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

Foto: Michel Euler/AP/Ritzau Scanpix

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

  1. Pfizer upgrades guidance for sales of covid-19 vaccine
  2. Pharma industry is discretely working against a global tax agreement
  3. GN Hearing top exec stops after 17 years – replacement found within own ranks
  4. Astrazeneca shot shows no increased clot risk after two doses
  5. Boston Scientific reports significant growth in endoscopy business – grows 54 percent
  6. Biontech plans to examine mRNA technology for malaria vaccines
  7. Nordic Capital in talks to buy healthtech firm Inovalon
  8. Pfizer and Biontech expand study of vaccines for children
  9. FDA gives Saniona candidate priority status
  10. Allarity keeps streamlining pipeline – sells cancer drug for USD 18m
  11. Sweden phases out AstraZeneca's covid-19 vaccine
  12. CHMP recommends Moderna covid-19 vaccine for approval in 12-17-year-olds
  13. CHMP recommends two new drugs for approval and rejects one
  14. Top news from MedWatch this week
  15. Roche's hemophilia treatment well on the way to triple blockbuster status

Jobs

See all jobs

See all jobs